诺舒阻抗控制子宫内膜切除系统治疗异常子宫出血120例临床分析.docx

歸阻抗控制子宫内膜切除裁治疗异常子宫出血120 例IIS粉析 2018-04-08 09:50:18中国现代医生2018年4期 熊夏思 ［摘要］戸的探讨诺舒(NovaSure)阻抗控制子宫内膜切除系统治疗异常子宫出血的有效性、 安全性及推广价值。方法 选取2015年1月?2017年4月本院诊断为异常子宫出血患者120例，所 有患者采用诺舒阻抗控制系统行子宫内膜切除术，术后仁3、6个月门诊随访，观察疗效及并发症。 结果120例患者均完成手术，诺舒治疗时间48?126 s,平均(84.1±19.2) s,术屮出血5?15 mL, 平均(9.5±0.7) mLo术后仁3、6个月的有效率分别为99% (118/120) 97% (116/120)和95% (114/120)；闭经率分别为 67.5% (81/120)、61.7% (74/120)和 57.5% (69/120)。术中及术 后均未出现明显并发症。结论诺舒治疗异常子宫出血具有安全、有效、治疗时间短、操作简单等优 点，近期疗效确切。 ［关键词］诺舒；子宫内膜切除；异常子宫出血；月经过多 ［中图分类号］R713.4 ［文献标识码］A ［文章编1673-9701 (2018) 04-0008-04 ［Abstract］ Objective To investigate the efficacy, safety and promotion value of NovaSure Resista nee and Control System for en dometrial exisi on in the treatment of abnormal uteri ne bleeding. Methods From January 2015 to April 2017, 120 patients with abnormal uterine bleeding who were diag no sed in our hospital were given en dometrial exision by NovaSure Resista nee and Control System. The patients were given follow-up visit one, three and six months after the surgery. The efficacy and complications were observed. Results 120 cases completed the surgery. The treatment time of NovaSure was 48? 126 s, The average was(84.1±19.2)s, and the intraoperative bleeding were 5?15 mL, with the average of (9.5±0.7) mL. The effective rates at 1, 3 and 6 months after surgery were 99% (118/120) , 97% (116/120) and 95% (114/120) respectively. The rate of amenorrhea was 67.5%(81/120), 61.7%(74/120) and 57.5%(69/120) respectively. There was no obvious complications during and after the surgery. Conclusion NovaSure in the treatment of abnormal uterine bleeding is safe and effective. ［Key words］ NovaSure； Endometrial exision； Abnormal uterine bleeding； Meno metrorrhagia 异常子宫出血(abnormal uterine bleeding, AUB)是指与正常J］经的周期、频率及经期持续吋 间、出血量等不同的来白子宫腔的异常出血。AUB是妇科内分泌门诊最常见的病种，常表现为月经 量多、周期紊乱或出血时间长，进而产生贫血、感染等一系列后果，严重影响女性的身体健康及生活 质量。对于异常了宫出血患者釆取及时有效的治疗至关重要［1］。近些年随着微创技术的不断发展，子 宫内膜去除术(endometrialablation, EA)由于其微创、操作简单、安全、有效等优点,得到妇科临 床医师及患者的充分肯定，广泛运用于无生育要求的AUB患者中。诺舒(NovaSure)阻